01 / LSTx
Lipid signalling therapeutics
Exploring lipid mediators as a source of new therapeutic compounds and biological opportunities.
Technology platforms
Complementary technologies. Multiple development routes.
Four chemistry-led platforms designed to generate compounds, applications and transferable therapeutic opportunities.
Explore the platformsOne development model
4Ammonium develops enabling technologies and applies them to create proprietary assets or new value for programmes brought by external partners.
The resulting opportunities can progress through licensing, co-development, scientific collaboration or dedicated ventures.
Technology → Results / Assets → Transfer
02 / NATx
Nucleic-acid therapeutics
Combining cationic lipid chemistry, proprietary oligonucleotide chemistry and covalent conjugation strategies.
03 / SMDC
Small Molecule Drug Conjugates
Small-molecule conjugates, engineered for tissue selectivity.
04 / Drug Rescue
Generating new opportunities from known drugs
Reformulation and therapeutic combinations designed to unlock renewed potential.
External programmes
Apply our technology to your development challenge
We can assess whether an existing 4Ammonium platform can create new value for a therapeutic hypothesis.
Discuss a programme